Collegium Pharma (COLL) Reports Q1 Loss of $1.05/Share

Collegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($1.05), versus ($0.45) reported last year.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24